Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine

Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences Vol. 455; p. 121116
Main Authors: Schwedt, Todd J., Myers Oakes, Tina M., Martinez, James M., Vargas, Bert B., Pandey, Hitendra N., Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Meyer, Michael Cobas, Goadsby, Peter J.
Format: Journal Article
Language:English
Published: 01-12-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0022-510X
DOI:10.1016/j.jns.2023.121116